GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] Denmark — has anyone got a straight answer on 503B — 32 comments in the full submission. View in context.
726
c/compounding·submitted 2 years ago by u/yannick_barros

[Question] Denmark — has anyone got a straight answer on 503B

Questionbranch of 10 comments

Genuine question, and the title is the question: Denmark — has anyone got a straight answer on 503B. The shortage list is the legal hinge: the permissions that allow certain compounding to happen at scale are tied to a drug’s shortage status, which changes. Compounded preparations are not approved products and carry…

Read the full submission and all 32 comments →

This branch

10 comments, started 2 years ago
u/solene_eriksen92 points·2 years ago

Potency and sterility testing on the finished preparation are separate from any certificate covering the starting material. Ask which you are being shown.

replysharereportpermalink
u/ahmed_okafor76 points·2 years ago

Nothing in this thread is medical advice, and the choice between arrangements is one for you and a prescriber who knows your history.

replysharereportpermalink
u/solene_eriksen18 points·2 years ago

Switched between two compounded preparations and the concentration on the label was different. Redid the arithmetic on paper before drawing anything.

replysharereportpermalink
u/usp_appendixcompendial22 points·2 years ago

A beyond-use date derived from published stability data means something different from one assigned by default rule. Asking which is a fair question and the answer is usually available.

replysharereportpermalink
u/ismael_pires5 points·2 years ago

ask what the beyond-use date is based on

replysharereportpermalink
u/rania_diallo15 points·2 years ago

Disagree — a 503B being registered does not make its preparations equivalent to an approved product. Different regulatory category entirely.

replysharereportpermalink
u/camila_mensa10 points·2 years ago

Not convinced. You are comparing a compounded concentration with a branded one and assuming they match.

replysharereportpermalink
u/kavya_kravchenko8 points·2 years ago

shortage status changes and the whole arrangement changes with it

replysharereportpermalink
u/eu_apotheke_a7 points·2 years ago

potency testing on the finished preparation is the thing to ask for

replysharereportpermalink
u/lift_heavy_thingsresistance training64 points·2 years ago·edited

the price difference is mostly the intake, not the vial

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.